| 0 (0%) | 09-27 11:15 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 55.6 | 1-year : | 58.35 |
| Resists | First : | 47.6 | Second : | 49.95 |
| Pivot price | 45.61  |
|||
| Supports | First : | 43.79 | Second : | 36.44 |
| MAs | MA(5) : | 44.84 |
MA(20) : | 45.95 |
| MA(100) : | 46.77  |
MA(250) : | 44.19 |
|
| MACD | MACD : | -1 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 3 |
D(3) : | 8.4 |
| RSI | RSI(14): 28.3 |
|||
| 52-week | High : | 51.88 | Low : | 37.63 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ QGEN ] has closed above bottom band by 3.2%. Bollinger Bands are 3.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 44.44 - 44.86 | 44.86 - 45.12 |
| Low: | 42.88 - 43.45 | 43.45 - 43.79 |
| Close: | 43.25 - 44.17 | 44.17 - 44.73 |
Thu, 25 Sep 2025
Qiagen N.V. (NYSE:QGEN) Is Largely Controlled by Institutional Shareholders Who Own 86% of the Company - 富途牛牛
Thu, 25 Sep 2025
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds - ADVFN
Wed, 24 Sep 2025
Berenberg Bank Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $59 - 富途牛牛
Mon, 22 Sep 2025
Qiagen (NYSE:QGEN) Valuation in Focus Following FDA Clearance and Expansion Plans in U.S. Diagnostics - simplywall.st
Sun, 21 Sep 2025
Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Sun, 21 Sep 2025
Acadian Asset Management LLC Has $1.14 Million Stake in QIAGEN N.V. $QGEN - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 217 (M) |
| Shares Float | 215 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 88.5 (%) |
| Shares Short | 6,720 (K) |
| Shares Short P.Month | 6,600 (K) |
| EPS | 1.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.17 |
| Profit Margin | 18.2 % |
| Operating Margin | 25.4 % |
| Return on Assets (ttm) | 9 % |
| Return on Equity (ttm) | 10.8 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 7.56 |
| Sales Per Share | 9.4 |
| EBITDA (p.s.) | 4.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 675 (M) |
| Levered Free Cash Flow | 683 (M) |
| PE Ratio | 25.97 |
| PEG Ratio | 0 |
| Price to Book value | 2.71 |
| Price to Sales | 4.66 |
| Price to Cash Flow | 14.1 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|